The relation between blood glucose and impedance isdetermined for each patient, using individual "artificial neural networks (ANN)" which have artificial intelligence. This procedure makes the calculation and representation of individual non-linear functions possible, as well as the intelligent processing of extensive amounts of data using stored physical, mathematical and physiological models.
NIVAB V03 was in a clinical trial (AWB) at the DCC in Karlsburg (Germany) and met the functional and technical requirements for medical devices. V03 was assessed according to appropriate standards, and for the above test by the German TÜV. The following figures show results from a collaboration with a diabetes surgery. (Click on German version)